Efficacy and safety of convalescent plasma therapy in patients with moderate-to-severe COVID-19: A non-randomized comparative study with historical control in a referral hospital in Indonesia

BACKGROUND: Studies to confirm the efficacy and safety of convalescent plasma (CP) as an adjunctive treatment for COVID-19 are still required especially for the countries where standard treatments are unevenly distributed. METHODS: A non-randomized comparative study was done from June – September 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurnianda, Johan, Hardianti, Mardiah S., Triyono, Teguh, Thobari, Jarir A., Trisnawati, Ika, Wisudarti, Calcarina F.R., Sukorini, Usi, Anshori, Fuad, Setiawan, Syahru A., Ucche, Meita, Farahnaz, Abrid, Suryani, Yana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579701/
https://www.ncbi.nlm.nih.gov/pubmed/34794908
http://dx.doi.org/10.1016/j.jiph.2021.10.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579701/
https://www.ncbi.nlm.nih.gov/pubmed/34794908
http://dx.doi.org/10.1016/j.jiph.2021.10.028

Ejemplares similares